MedTech News
.................... by Andrew Celentano
Glaukos gets FDA nod for iDose TR re-administration
Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR system.
Designing the future of metabolic health through tissue-selective drug delivery
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
FDA clears Spectrum Dynamics’ Veritas.AI platform
Veritas.AI is designed to advance the functionality of Spectrum Dynamics’ VERITON-CT scanner for nuclear imaging.
KORU Medical receives FDA clearance for FreedomEDGE infusion system
Rystiggo is administered weekly, 3ml to 6ml over 15 to 30 minutes for six weeks.
Top medtech trends to watch in 2026
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.
RevBio receives FDA clearance for cranial bone glue trial
The FDA has authorised up to 15 clinical sites to take part in the study.
Imperative Care launches new Zoom 4S catheter
Imperative Care announced the launch of the new Zoom 4S thrombectomy catheter and reported the first patient cases with the device.
The top 10 cardio device stories of 2025
Pulsed-field ablation, transcatheter heart valves, and intravascular lithotripsy are among the top stories, as they drive growth among the largest cardio device companies.